论文部分内容阅读
6-甲基强的松龙(6-MPSL)常用于治疗难治性肾病、重症肌无力、系统性红斑狼疮、免疫性神经疾患、难治性血小板减少性紫癜及自身免疫性溶血性贫血等。近年来国内外均有应用大剂量6-MPSL治疗严重型再生障碍性贫血(SAA),取得近期满意效果。特别是伴有大出血病人,止血效果令人满意。我们于1990年应用大剂量6-MPSL治疗SAA2例,报道如下。
6-methylprednisolone (6-MPSL) is commonly used in the treatment of refractory nephropathy, myasthenia gravis, systemic lupus erythematosus, immune neuropathy, refractory thrombocytopenic purpura and autoimmune hemolytic anemia . In recent years, both at home and abroad have applied large doses of 6-MPSL treatment of severe aplastic anemia (SAA), and achieved satisfactory results in the near future. Especially with bleeding patients, hemostatic effect is satisfactory. In 1990, we applied high-dose 6-MPSL treatment of SAA2 cases, reported as follows.